12:00 AM
 | 
Sep 10, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Multipotent bone marrow-derived stem cells: Phase II started

AlloCure began the double-blind, placebo-controlled, U.S. Phase II ACT-AKI trial to evaluate a single dose of AC607 in 200 cardiac surgery patients who experienced kidney injury...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >